Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wuxi PharmaTech To Build Largest Preclinical Drug Safety Center In China

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Chinese pharmaceutical R&D outsourcing services provider WuXi PharmaTech will invest $40 million to build its first good laboratory practices center in Suzhou. The GLP center will be the largest modern drug safety evaluation center in China, the New York Stock Exchange-listed company said Oct. 9

You may also be interested in...



China Offers Playground Of Opportunity For Trying Out Different Models, Risks - Shanghai R&D Summit

SHANGHAI - The rapid transformation of China's pharmaceutical and biotech sector reveals the changing face of this nation and the realization that China is more dynamic than developed markets such as the U.S. and Europe and is a good place to try out different models and approaches to R&D, presenters at the China R&D Summit told attendees April 7

China Offers Playground Of Opportunity For Trying Out Different Models, Risks - Shanghai R&D Summit

SHANGHAI - The rapid transformation of China's pharmaceutical and biotech sector reveals the changing face of this nation and the realization that China is more dynamic than developed markets such as the U.S. and Europe and is a good place to try out different models and approaches to R&D, presenters at the China R&D Summit told attendees April 7

China’s WuXi To Acquire U.S.-Based AppTec Laboratory Services

SHANGHAI - WuXi PharmaTech will acquire U.S.-based AppTec Laboratory Services, the Chinese pharma outsourcing company announced Jan. 3

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel